Respiratory Distress Syndrome
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection [Phase 2]
Phase 2 trial evaluating fibrinolytic therapy for acute respiratory distress syndrome associated with COVID-19 has completed; results posted…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE) [Phase 3]
Phase 3 trial evaluating aerosolized Dornase Alfa for efficacy and safety in COVID-19–induced ARDS has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Iloprost in Acute Respiratory Distress Syndrome [Phase 3]
Phase 3 clinical trial of iloprost for acute respiratory distress syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes [Phase 1, Phase 2]
Phase 1/2 trial update on LEAF-4L6715 (liposomal trans-crocetin) for acute respiratory distress syndrome related to COVID-19, sepsis, or oth…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) [Phase 2]
Phase 2 trial assessing Gimsilumab for efficacy and safety in COVID-19–related lung injury and ARDS; study completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Use of UC-MSCs for COVID-19 Patients [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating umbilical cord-derived mesenchymal stem cells (UC-MSCs) for COVID-19-related ARDS.
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE [NA]
A terminated clinical trial investigating awake prone positioning to reduce invasive ventilation in COVID-19–related acute respiratory failu…
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease [Phase 2]
Phase 2 clinical trial assessing oral lactoferrin as a safe antiviral and immunoregulatory treatment for COVID-19 and related coronavirus in…
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: London's Exogenous Surfactant Study for COVID19 [Phase 1, Phase 2]
Phase 1/2 trial of exogenous surfactant for ARDS in COVID-19 completed in London.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response [Phase 4]
A Phase 4 clinical trial updates booster dosing of a COVID-19 vaccine in kidney transplant recipients who lacked an adequate humoral respons…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19 [Phase 2]
Phase 2 trial updating low-dose interleukin-2 for acute respiratory distress syndrome related to COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease [Phase 4]
A Phase 4 clinical trial evaluating valsartan for prevention of acute respiratory distress syndrome in hospitalized COVID-19 patients was te…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19 [Phase 2]
Phase 2 clinical trial update for Glenzocimab in SARS-CoV-2–associated acute respiratory distress syndrome (COVID-19).
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update on MultiStem administration for COVID-19-induced ARDS (MACoVIA) with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: Ventilator-induced Lung Injury Vortex in Patients With SARS-CoV-2
Clinical trial on ventilator-induced lung injury in patients with SARS-CoV-2 has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS [Phase 2]
Phase 2 trial evaluating ruxolitinib for COVID-19–induced acute respiratory distress syndrome (ARDS) has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Polyvalent Immunoglobulin in COVID-19 Related ARds [Phase 3]
Phase 3 trial update on polyvalent immunoglobulin for COVID-19 related acute respiratory distress syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-04Clinical Trial Update: Sleep Intervention During Acute Lung Injury [Phase 4]
Phase 4 clinical trial update on sleep intervention during acute lung injury/critical illness has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: ART-2 Pilot - Driving Pressure Limited Ventilation for Patients With ARDS [Phase 1, Phase 2]
A pilot study (Phase 1/2) evaluating driving pressure limited ventilation in patients with Acute Respiratory Distress Syndrome has completed…
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection [Phase 4]
Phase 4 trial comparing sedation with sevoflurane versus propofol in COVID-19–associated acute respiratory distress syndrome has been termin…
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Sevoflurane in COVID-19 ARDS (SevCov) [Phase 3]
Phase 3 clinical trial investigating sevoflurane for COVID-19 ARDS has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 [Phase 2]
A Phase 2 clinical trial evaluating hydroxychloroquine plus azithromycin for prevention and treatment of acute respiratory syndrome caused b…
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Pre-exposure Prophylaxis for SARS-Coronavirus-2 [Phase 3]
Phase 3 trial update on pre-exposure prophylaxis for SARS-CoV-2 completed with posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia [Phase 2]
Phase 2 clinical trial update evaluating FX06 to rescue acute respiratory distress syndrome in COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Tocilizumab for Patients With Cancer and COVID-19 Disease [Phase 2]
Phase 2 trial evaluating tocilizumab in cancer patients with COVID-19 was terminated; results were posted in June 2021.